Febe van Maldegem

2.0k total citations
20 papers, 858 citations indexed

About

Febe van Maldegem is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Febe van Maldegem has authored 20 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Immunology. Recurrent topics in Febe van Maldegem's work include Cancer Immunotherapy and Biomarkers (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Febe van Maldegem is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Febe van Maldegem collaborates with scholars based in Netherlands, United Kingdom and United States. Febe van Maldegem's co-authors include Richard J. Bende, Carel J.M. van Noesel, Jan Aten, Mirza M. Idu, Allard C. van der Wal, Onno J. de Boer, J. J. van der Meer, Thera A.M. Wormhoudt, Chris M. van der Loos and Peter Teeling and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Febe van Maldegem

20 papers receiving 846 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Febe van Maldegem Netherlands	12	312	307	235	201	114	20	858
Evelien Schaafsma United States	13	226 0.7×	294 1.0×	336 1.4×	115 0.6×	140 1.2×	30	801
Walter Hanel United States	12	418 1.3×	287 0.9×	436 1.9×	165 0.8×	225 2.0×	39	910
Markus Möbs Germany	19	237 0.8×	240 0.8×	303 1.3×	250 1.2×	116 1.0×	42	802
Samir Tawadros Germany	16	254 0.8×	352 1.1×	225 1.0×	100 0.5×	69 0.6×	34	863
Keiichiro Honma Japan	14	283 0.9×	283 0.9×	471 2.0×	366 1.8×	286 2.5×	82	1.0k
Jeffrey P. Zwerner United States	15	331 1.1×	219 0.7×	288 1.2×	329 1.6×	90 0.8×	33	1.0k
Elisabetta Caprini Italy	19	514 1.6×	375 1.2×	307 1.3×	246 1.2×	150 1.3×	41	1.2k
Raquel Pajares Spain	10	351 1.1×	198 0.6×	536 2.3×	320 1.6×	131 1.1×	12	887
Georgios Z. Rassidakis United States	17	489 1.6×	234 0.8×	414 1.8×	375 1.9×	96 0.8×	34	1.0k
Raphael Koch Germany	11	753 2.4×	259 0.8×	334 1.4×	210 1.0×	375 3.3×	33	1.2k

Countries citing papers authored by Febe van Maldegem

Since Specialization

Citations

This map shows the geographic impact of Febe van Maldegem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Febe van Maldegem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Febe van Maldegem more than expected).

Fields of papers citing papers by Febe van Maldegem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Febe van Maldegem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Febe van Maldegem. The network helps show where Febe van Maldegem may publish in the future.

Co-authorship network of co-authors of Febe van Maldegem

This figure shows the co-authorship network connecting the top 25 collaborators of Febe van Maldegem. A scholar is included among the top collaborators of Febe van Maldegem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Febe van Maldegem. Febe van Maldegem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bahce, Idris, Chris Dickhoff, Famke L. Schneiders, et al.. (2024). Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE study. Journal for ImmunoTherapy of Cancer. 12(9). e009799–e009799. 5 indexed citations

Magness, Alastair, Emma Colliver, Katey S.S. Enfield, et al.. (2024). Deep cell phenotyping and spatial analysis of multiplexed imaging with TRACERx-PHLEX. Nature Communications. 15(1). 5135–5135. 2 indexed citations

Mugarza, Edurne, Febe van Maldegem, Jesse Boumelha, et al.. (2022). Therapeutic KRAS ^G12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers. Science Advances. 8(29). eabm8780–eabm8780. 73 indexed citations

Maldegem, Febe van, et al.. (2022). MA12.03 Mechanims of Immune Evasion in Patients With KRAS-Mutant Lung Adenocarcinoma: A Role of MAPK Pathway Activation. Journal of Thoracic Oncology. 17(9). S84–S85. 1 indexed citations

Maldegem, Febe van, Harshil Patel, Mihaela Angelova, et al.. (2021). Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry. Nature Communications. 12(1). 5906–5906. 41 indexed citations

Mugarza, Edurne, Febe van Maldegem, Jesse Boumelha, et al.. (2021). Abstract P111: Therapeutic KRASG12C inhibition alleviates KRAS-driven immunosuppression. Molecular Cancer Therapeutics. 20(12_Supplement). P111–P111. 1 indexed citations

Molina‐Arcas, Míriam, Christopher Moore, Sareena Rana, et al.. (2019). Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer. Science Translational Medicine. 11(510). 146 indexed citations

Molina‐Arcas, Míriam, Christopher Moore, Sareena Rana, et al.. (2018). 15 Identification of new combination therapies for lung cancer tumours harbouring KRAS mutations. ESMO Open. 3. A7–A7. 1 indexed citations

Maldegem, Febe van, Sarah Maslen, C. Mark Johnson, et al.. (2015). CTNNBL1 facilitates the association of CWC15 with CDC5L and is required to maintain the abundance of the Prp19 spliceosomal complex. Nucleic Acids Research. 43(14). 7058–7069. 13 indexed citations

10.

Ganesh, Karuna, Febe van Maldegem, Stéphanie B. Telerman, et al.. (2013). Structural and mutational analysis reveals that CTNNBL1 binds NLSs in a manner distinct from that of its closest armadillo‐relative, karyopherin α. FEBS Letters. 588(1). 21–27. 4 indexed citations

11.

Chandra, Anita, Febe van Maldegem, Simon Andrews, Michael S. Neuberger, & Cristina Rada. (2013). Deficiency in spliceosome-associated factor CTNNBL1 does not affect ongoing cell cycling but delays exit from quiescence and results in embryonic lethality in mice. Cell Cycle. 12(5). 732–742. 11 indexed citations

12.

Maldegem, Febe van, Thera A.M. Wormhoudt, Monique E.C.M. Oud, et al.. (2012). Chlamydia psittaci-negative ocular adnexal marginal zone B-cell lymphomas have biased VH4-34 immunoglobulin gene expression and proliferate in a distinct inflammatory environment. Leukemia. 26(7). 1647–1653. 24 indexed citations

13.

Maldegem, Febe van, et al.. (2010). Activation-Induced Cytidine Deaminase Splice Variants Are Defective Because of the Lack of Structural Support for the Catalytic Site. The Journal of Immunology. 184(5). 2487–2491. 9 indexed citations

14.

Bende, Richard J., Febe van Maldegem, & C. J. M. van Noesel. (2009). Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas. Haematologica. 94(8). 1109–1123. 61 indexed citations

15.

Boer, Onno J. de, J. J. van der Meer, Peter Teeling, et al.. (2009). Differential expression of interleukin‐17 family cytokines in intact and complicated human atherosclerotic plaques. The Journal of Pathology. 220(4). 499–508. 166 indexed citations

16.

Maldegem, Febe van, et al.. (2008). Effects of Processing Delay, Formalin Fixation, and Immunohistochemistry on RNA Recovery From Formalin-fixed Paraffin-embedded Tissue Sections. Diagnostic Molecular Pathology. 17(1). 51–58. 58 indexed citations

17.

Maldegem, Febe van, Remco van Dijk, Thera A.M. Wormhoudt, et al.. (2008). The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment. Blood. 112(8). 3355–3361. 76 indexed citations

18.

Bende, Richard J., et al.. (2007). Germinal centers in human lymph nodes contain reactivated memory B cells. The Journal of Experimental Medicine. 204(11). 2655–2665. 54 indexed citations

19.

Smit, Laura A., Febe van Maldegem, Anton W. Langerak, et al.. (2006). Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation.. PubMed. 91(7). 903–11. 17 indexed citations

20.

Mook, Olaf R.F., et al.. (2003). In Situ Localization of Gelatinolytic Activity in the Extracellular Matrix of Metastases of Colon Cancer in Rat Liver Using Quenched Fluorogenic DQ-gelatin. Journal of Histochemistry & Cytochemistry. 51(6). 821–829. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact